Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.2K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.2K
General Transcription Factors01:30

General Transcription Factors

5.1K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
5.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Theoretical investigation of active dual-band tuning of dielectric chiral metasurfaces via Q-BICs.

Optics express·2026
Same author

Dynamic topological charge switching in vortex beam generation using phase-change materials.

Optics express·2025
Same author

Potential causal link between antiseizure medication targets and cognitive function: A mendelian randomization study.

Progress in neuro-psychopharmacology & biological psychiatry·2025
Same author

Loss of CD99L2 Contributed to Temozolomide Resistance and Glioblastoma Tumorigenesis Based on Genome-scale CRISPR/Cas9 Screening.

Current pharmaceutical design·2025
Same author

Energy restriction inhibits β-catenin ubiquitination to improve ischemic stroke injury via USP18/SKP2 axis.

Metabolic brain disease·2024
Same author

A potassium-chloride co-transporter with altered genome architecture functions as a suppressor in glioma.

Journal of cellular and molecular medicine·2024

Related Experiment Video

Updated: May 13, 2025

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

6.6K

Identification of Versican as a target gene of the transcription Factor ZNF587B in ovarian cancer.

Lu Zhou1, Mengke Cui1, Jian Yu1

  • 1Department of Clinical Pharmacology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410008, PR China; National Laboratory of Medical Genetics, Central South University, Changsha 410078, PR China.

Biochemical Pharmacology
|April 14, 2025
PubMed
Summary
This summary is machine-generated.

This study reveals zinc finger protein ZNF587B suppresses ovarian cancer by repressing Versican (VCAN) expression. Reduced ZNF587B and increased VCAN correlate with poorer patient prognosis, suggesting a new therapeutic target.

Keywords:
AKTOvarian CancerVCANZNF587B

More Related Videos

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

12.2K
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

2.5K

Related Experiment Videos

Last Updated: May 13, 2025

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

6.6K
Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

12.2K
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

2.5K

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Ovarian cancer is a lethal gynecologic malignancy with high mortality.
  • Zinc finger protein ZNF587B was previously identified as a potential suppressor of ovarian cancer cell growth.
  • The precise molecular mechanisms underlying ZNF587B's tumor-suppressive role require elucidation.

Purpose of the Study:

  • To investigate the molecular mechanism by which ZNF587B suppresses ovarian cancer.
  • To determine if ZNF587B directly regulates Versican (VCAN) expression.
  • To explore the clinical significance of ZNF587B and VCAN expression in ovarian cancer patients.

Main Methods:

  • Chromatin immunoprecipitation-quantitative PCR (ChIP-qPCR) to assess ZNF587B binding to the VCAN promoter.
  • Luciferase reporter assays to confirm transcriptional repression of VCAN by ZNF587B.
  • In vivo and in vitro assays to evaluate the role of VCAN in ZNF587B-mediated ovarian cancer cell proliferation.
  • Immunofluorescence (IF) for protein localization.
  • Analysis of patient data correlating ZNF587B and VCAN expression with prognosis.

Main Results:

  • ZNF587B directly binds to the promoter region of Versican (VCAN) and represses its transcription.
  • Knockdown of ZNF587B increases ovarian cancer cell proliferation, an effect potentially mediated by VCAN.
  • Reduced ZNF587B expression and elevated VCAN expression are associated with a poorer prognosis in ovarian cancer patients.
  • The mechanism may involve alterations in AKT phosphorylation.

Conclusions:

  • ZNF587B functions as a tumor suppressor in ovarian cancer by directly inhibiting VCAN transcription.
  • The ZNF587B/VCAN axis represents a potential prognostic biomarker and therapeutic target for ovarian cancer.
  • Further research into the AKT pathway's role is warranted.